Hence, despite the beneficial effect shown in the present work (summarized in Figure 5), previous studies by our group demonstrated that ACE2 deletion leads to endothelial dysfunction and vascular oxidative stress [22], as well as steatosis and impaired insulin signaling in the liver [18]. The gene discussed is ACE2; the disease is endothelial dysfunction.